Cathepsin-S as a novel direct drug target for preventing barrier and tissue destructive proinflammatory IL-1 beta signaling in primary, vascular endothelium: an in vitro study
Funding Agency : DST SERB
Ongoing
Principal Investigator
2962650
2021 -
continue
Cathepsin-S as a novel direct drug target for preventing barrier and tissue destructive proinflammatory IL-1 beta signaling in primary, vascular endothelium: an in vitro study